✦ LIBER ✦
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
✍ Scribed by David A. Morrow; Chaim M. Brickman; Sabina A. Murphy; Kenneth Baran; Ricardo Krakover; Harold Dauerman; Sujatha Kumar; Natanya Slomowitz; Laura Grip; Carolyn H. McCabe; Andrew L. Salzman
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 258 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0929-5305
No coin nor oath required. For personal study only.